Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;104:I-64-I-67
doi: 10.1161/hc37t1.094819
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gaudino, M.
Right arrow Articles by Possati, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gaudino, M.
Right arrow Articles by Possati, G.
Related Collections
Right arrow CV surgery: coronary artery disease

(Circulation. 2001;104:I-64.)
© 2001 American Heart Association, Inc.


Surgery for Coronary Artery Disease

Clinical and Angiographic Effects of Chronic Calcium Channel Blocker Therapy Continued Beyond First Postoperative Year in Patients With Radial Artery Grafts

Results of a Prospective Randomized Investigation

Mario Gaudino, MD; Franco Glieca, MD; Nicola Luciani, MD; Francesco Alessandrini, MD; Gianfederico Possati, MD

Department of Cardiac Surgery, Catholic University, Rome, Italy.

Correspondence to Mario Gaudino, MD, Divisione di Cardiochirurgia, Policlinico Universitario A. Gemelli, Largo A. Gemelli 8, 00168 Rome, Italy. E-mail mgaudino{at}tiscalinet.it

Background— This study was conceived to elucidate the clinical and angiographic effects of chronic calcium channel blocker therapy (CCCBT) continued after the first postoperative year in patients in whom the radial artery (RA) was used for myocardial revascularization.

Methods and Results— Patients who received RA grafts at our institution and who at 1 year had no scintigraphic evidence of ischemia in the RA territory or angiographic evidence of RA malfunction (n=120) were randomly assigned to continue (n=63) or suspend (n=57) the CCCBT with diltiazem (120 mg/d). After 5 years, all patients were reassessed clinically and by stress myocardial scintigraphy, and 87 of them (45 from the continued group that continued CCCBT and 42 from the group that suspended CCCBT) were restudied angiographically. No differences regarding either the clinical and scintigraphic results or the RA angiographic status were demonstrated between the 2 groups.

Conclusions— After the first postoperative year, the continuation of CCCBT does not affect RA graft patency or clinical and scintigraphic results.


Key Words: arteries • coronary disease • surgery